Journal articles on the topic 'Philip Johnson Associates'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 43 journal articles for your research on the topic 'Philip Johnson Associates.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Chohan, S., A. Kavanaugh, V. Strand, R. C. Chou, A. M. Mendelsohn, S. Rozzo, and P. J. Mease. "AB0803 EFFICACY OF TILDRAKIZUMAB IN PsA: DAS28-CRP SCORES THROUGH WEEK 52." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1702–3. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3907.
Full textJayne, D., P. Gavin, E. Allman, C. Di Poto, X. Tian, S. Hess, M. Ramaswamy, et al. "OP0136 METABOLOMIC SERUM PROFILING IDENTIFIES METABOLITES LINKED TO KIDNEY DAMAGE WHICH ARE MODULATED BY ANIFROLUMAB IN A PHASE 2 TRIAL IN LUPUS NEPHRITIS." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 90.1–90. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1569.
Full textPray, C., N. Narula, E. C. Wong, J. K. Marshall, S. Rangarajan, S. Islam, A. Bahonar, et al. "A176 ASSOCIATIONS OF ANTIBIOTICS, HORMONAL THERAPIES, ORAL CONTRACEPTIVES, AND LONG-TERM NSAIDS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY." Journal of the Canadian Association of Gastroenterology 6, Supplement_1 (March 1, 2023): 20–22. http://dx.doi.org/10.1093/jcag/gwac036.176.
Full textRahman, P., C. T. Ritchlin, P. Helliwell, W. H. Boehncke, P. J. Mease, A. B. Gottlieb, S. Kafka, et al. "FRI0359 INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 776–77. http://dx.doi.org/10.1136/annrheumdis-2020-eular.387.
Full textRahman, P., P. J. Mease, A. Deodhar, A. Kavanaugh, S. D. Chakravarty, A. Kollmeier, Y. Liu, M. Shawi, and C. Han. "OP0025 FACTORS ASSOCIATED WITH FATIGUE AND ITS IMPROVEMENT – A PRINCIPAL COMPONENT ANALYSIS OF PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS FROM GUSELKUMAB PHASE 3 TRIALS." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 18–19. http://dx.doi.org/10.1136/annrheumdis-2022-eular.895.
Full textCoates, L. C., C. T. Ritchlin, L. Gossec, P. Helliwell, P. Rahman, E. C. Hsia, A. Kollmeier, et al. "POS1024 GUSELKUMAB PROVIDES SUSTAINED DOMAIN-SPECIFIC AND COMPREHENSIVE EFFICACY AS ASSESSED USING COMPOSITE ENDPOINTS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 781–82. http://dx.doi.org/10.1136/annrheumdis-2021-eular.167.
Full textCurtis, J., I. Mcinnes, D. D. Gladman, F. Yang, S. Peterson, P. Agarwal, A. Kollmeier, et al. "POS1028 PATIENT CHARACTERISTICS & CLINICAL FEATURES ASSOCIATE WITH HEALTH-RELATED QUALITY OF LIFE IN BIO-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH WEEK 24 OF THE DISCOVER-2 STUDY." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 784–85. http://dx.doi.org/10.1136/annrheumdis-2021-eular.432.
Full textCoates, L., J. Ramírez, D. Mcgonagle, S. Aydin, M. Zimmermann, F. Nantel, M. Shawi, E. Rampakakis, P. Nash, and P. J. Mease. "POS1540 EARLY SKIN AND EARLY ENTHESITIS RESPONSES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB ASSOCIATE WITH LONG-TERM RESPONSE: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3 STUDY." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 1137.1–1137. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2581.
Full textMcgonagle, D., I. Mcinnes, A. Deodhar, G. Schett, P. J. Mease, M. Shawi, S. Kafka, et al. "AB0801 EFFECTS OF GUSELKUMAB, A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO THE P19-SUBUNIT OF INTERLEUKIN-23, ON DACTYLITIS AND ENTHESITIS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED RESULTS THROUGH WEEK 24 FROM TWO PHASE 3 STUDIES." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1701.2–1701. http://dx.doi.org/10.1136/annrheumdis-2020-eular.836.
Full textCurtis, J., I. McInnes, P. Rahman, D. D. Gladman, F. Yang, S. Peterson, A. Kollmeier, et al. "AB0881 Guselkumab Provides Sustained Improvements in Health-Related Quality of Life in Patients With Active Psoriatic Arthritis Through 2 Years of DISCOVER-2." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1563.2–1564. http://dx.doi.org/10.1136/annrheumdis-2022-eular.733.
Full textGossec, L., D. Aletaha, P. Sewerin, A. Zabotti, F. Van den Bosch, M. Efficace, F. Lavie, M. Zimmermann, M. Sharaf, and I. Mcinnes. "AB1082 EARLY CLINICAL RESPONSE AS A PREDICTOR OF LONG-TERM HEALTH-RELATED QUALITY OF LIFE IMPROVEMENTS IN PATIENTS WITH PSORIATIC ARTHRITIS AND TNFI-IR RECEIVING GUSELKUMAB (COSMOS)." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 1761.1–1761. http://dx.doi.org/10.1136/annrheumdis-2023-eular.359.
Full textSewerin, P., L. Dötsch, D. Truhm, D. Abrar, and S. Nebelung. "THU0062 FUNCTIONAL MR IMAGING OF HUMAN MENISCUS IS ASSOCIATED WITH HISTOLOGICAL DEGENERATION." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 243. http://dx.doi.org/10.1136/annrheumdis-2020-eular.6403.
Full textCoates, L., I. Mcinnes, S. Aydin, M. Kishimoto, P. J. Mease, M. Shawi, M. Zimmermann, E. Rampakakis, F. Lavie, and D. Mcgonagle. "POS0027 INDIVIDUAL ENTHESEAL POINTS HAVE DIFFERENTIAL FREQUENCY OF INVOLVEMENT AND IMPACT ON PATIENT REPORTED OUTCOMES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 220–21. http://dx.doi.org/10.1136/annrheumdis-2023-eular.122.
Full textCurtis, J., I. Mcinnes, S. Peterson, P. Agarwal, F. Yang, A. Kollmeier, E. C. Hsia, et al. "POS1026 GUSELKUMAB PROVIDES SUSTAINED IMPROVEMENTS IN WORK PRODUCTIVITY AND NON-WORK ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS THROUGH 1 YEAR OF A PHASE 3 TRIAL." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 782.2–783. http://dx.doi.org/10.1136/annrheumdis-2021-eular.244.
Full textNash, P., I. Mcinnes, C. T. Ritchlin, L. S. Tam, E. Soriano, M. Starr, E. Rampakakis, et al. "AB1095 IMPACT OF PSORIATIC ARTHRITIS MANIFESTATIONS ON PERCEPTION OF PAIN IMPROVEMENT: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES WITH GUSELKUMAB." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 1771–72. http://dx.doi.org/10.1136/annrheumdis-2023-eular.555.
Full textBaraliakos, X., D. D. Gladman, S. D. Chakravarty, C. Gong, M. Shawi, E. Rampakakis, M. Kishimoto, E. Soriano, and P. J. Mease. "POS0023 PERFORMANCE OF BASDAI VS. ASDAS IN EVALUATING AXIAL INVOLVEMENT IN PATIENTS WITH PSA TREATED WITH GUSELKUMAB: POOLED ANALYSIS OF TWO PHASE 3 STUDIES." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 217.2–218. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2761.
Full textGladman, D. D., M. Starr, R. Ranza, A. M. Bravo Perdomo, M. Strauss, M. Shawi, C. Han, E. Rampakakis, A. Andrew Östör, and P. J. Mease. "AB1087 LONG-TERM EFFICACY OF GUSELKUMAB IN FATIGUE AND IDENTIFICATION OF EARLY TREATMENT TARGETS: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 1765.1–1765. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1918.
Full textMease, P. J., P. Foley, K. Reich, J. Bagel, M. Lebwohl, Y. W. Yang, M. Shawi, et al. "POS1031 LOW INCIDENCE OF GASTROINTESTINAL-RELATED AND OVERALL SERIOUS ADVERSE EVENTS AMONG GUSELKUMAB-TREATED PATIENTS: POOLED ANALYSES OF VOYAGE 1 & 2 AND DISCOVER 1 & 2 THROUGH 1-YEAR." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 787–88. http://dx.doi.org/10.1136/annrheumdis-2021-eular.558.
Full textOrbai, A. M., L. C. Coates, A. Deodhar, P. Helliwell, C. T. Ritchlin, A. Kollmeier, E. C. Hsia, et al. "POS1029 GUSELKUMAB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS ACHIEVED CLINICALLY MEANINGFUL IMPROVEMENTS IN GENERAL HEALTH OUTCOMES MEASURED WITH PROMIS-29 THROUGH 52 WEEKS: RESULTS FROM THE PHASE 3 DISCOVER-1 TRIAL." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 785–86. http://dx.doi.org/10.1136/annrheumdis-2021-eular.471.
Full textCurtis, J., I. Mcinnes, P. Rahman, D. D. Gladman, F. Yang, S. Peterson, A. Kollmeier, et al. "AB0888 Guselkumab Provides Sustained Improvements in Work Productivity and Daily Activity in Patients With Active Psoriatic Arthritis Through 2 Years of DISCOVER-2." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1568–69. http://dx.doi.org/10.1136/annrheumdis-2022-eular.1366.
Full textCoates, L., P. Rahman, P. J. Mease, M. Shawi, E. Rampakakis, A. Kollmeier, X. L. Xu, S. D. Chakravarty, I. Mcinnes, and L. S. Tam. "POS1067 DOMAINS CONTRIBUTING TO MINIMAL DISEASE ACTIVITY ACHIEVEMENT IN PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING GUSELKUMAB." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 856–57. http://dx.doi.org/10.1136/annrheumdis-2022-eular.893.
Full textRitchlin, C. T., P. J. Mease, W. H. Boehncke, J. Tesser, S. D. Chakravarty, E. Rampakakis, M. Shawi, et al. "AB1104 STRINGENT DISEASE ACTIVITY CONTROL AT 2 YEARS ACROSS PSORIATIC ARTHRITIS DOMAINS IRRESPECTIVE OF BASELINE CHARACTERISTICS IN PATIENTS TREATED WITH GUSELKUMAB: POST-HOC ANALYSIS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 1779–80. http://dx.doi.org/10.1136/annrheumdis-2023-eular.3238.
Full textTillett, W., L. Coates, M. Vis, E. Soriano, J. F. Merola, M. Zimmermann, M. Shawi, M. Sharaf, P. Nash, and P. Helliwell. "POS1535 EARLY IMPROVEMENT IN 3VAS/4VAS PREDICTS REDUCED RATES OF RADIOGRAPHIC CHANGE IN BIO-NAIVE ACTIVE PSORIATIC ARTHRITIS PATIENTS RECEIVING GUSELKUMAB TREATMENT." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 1131–32. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1690.
Full textDu, Wenxuan, Adrian Johnston, Praful Nair, Jingyi Zhu, Khin Sandar Win, Bryan Zhou, Jude Phillip, Pei-Hsun Wu, and Denis Wirtz. "Abstract 5949: Modulate TAM infiltration at cancer-immune interface by targeting at monocyte migration." Cancer Research 83, no. 7_Supplement (April 4, 2023): 5949. http://dx.doi.org/10.1158/1538-7445.am2023-5949.
Full textLippert, Anna L., Katherine A. Johnson, Cheri A. Pasch, Sean G. Kraus, Philip B. Emmerich, Linda Clipson, Kristina A. Matkowskyj, Wei Zhang, and Dustin A. Deming. "Abstract 3198: Validation and analysis of cancer associated fibroblast subtype markers in metastatic colorectal cancer." Cancer Research 82, no. 12_Supplement (June 15, 2022): 3198. http://dx.doi.org/10.1158/1538-7445.am2022-3198.
Full textGudikote, Jayanthi, Tina Cascone, Alissa Poteete, Piyada Sitthideatphaiboon, Sonia Patel, Yan Yang, Fahao Zhang, et al. "Abstract 5733: Targeting nonsense-mediated decay restores p53 function in HPV-associated head and neck cancers." Cancer Research 82, no. 12_Supplement (June 15, 2022): 5733. http://dx.doi.org/10.1158/1538-7445.am2022-5733.
Full textTaylor, P. C., K. De Vlam, A. G. Bushmakin, L. Fallon, J. F. Merola, J. C. Cappelleri, M. A. Hsu, and P. J. Mease. "AB0838 IDENTIFYING MEDIATORS OF PAIN REDUCTION IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH TOFACITINIB: ROLE OF INFLAMMATION ASSOCIATED WITH PERIPHERAL ARTHRITIS, ENTHESITIS AND SKIN DISEASE." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1724–25. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1052.
Full textJohnson, Katherine Anne, Anna L. Lippert, Sean G. Kraus, Grace E. McGrath, Philip B. Emmerich, Cheri A. Pasch, Linda Clipson, Kristina A. Matkowskyj, Wei Zhang, and Dustin A. Deming. "Abstract 3533: Effects of tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib on cancer-associated fibroblast phenotypes in colorectal cancer." Cancer Research 82, no. 12_Supplement (June 15, 2022): 3533. http://dx.doi.org/10.1158/1538-7445.am2022-3533.
Full textDale, David, Audrey Anna Bolyard, Emily Dick, Merideth L. Kelley, Vahagn Makaryan, Ramsey Johnson, Lu Gan, and Sudha Parasuraman. "X4P-001: A Novel Molecularly-Targeted Oral Therapy for Whim Syndrome." Blood 130, Suppl_1 (December 7, 2017): 995. http://dx.doi.org/10.1182/blood.v130.suppl_1.995.995.
Full textChaudhuri, Somak, Dustin A. Deming, Cheri A. Pasch, Katherine A. Johnson, Chelsie K. Sievers, and Philip B. Emmerich. "Abstract 1581: Colony-stimulating factor-1 receptor as a potential therapeutic target in pancreatic ductal adenocarcinoma." Cancer Research 84, no. 6_Supplement (March 22, 2024): 1581. http://dx.doi.org/10.1158/1538-7445.am2024-1581.
Full textBrooks, J., A. Montgomery, N. Dalbeth, M. Sapsford, A. Cooper, R. Ngan Kee, V. Quincey, et al. "OP0079 OMICRON VARIANT INFECTION IN INFLAMMATORY RHEUMATOLOGICAL CONDITIONS - OUTCOMES FROM A COVID-19 NAIVE POPULATION IN AOTEAROA NEW ZEALAND." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 54–55. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1749.
Full textHilliard, Tyvette, Phillip Petrasko, Yueying Liu, Jing Yang, Marwa Asem, Jeff Johnson, Gifty Marfowaa, et al. "Abstract 2189: The role of generational obesity on the ovarian metastatic niche." Cancer Research 82, no. 12_Supplement (June 15, 2022): 2189. http://dx.doi.org/10.1158/1538-7445.am2022-2189.
Full textGossec, L., P. J. Mease, A. B. Gottlieb, A. Ogdie, D. Assudani, J. Coarse, B. Ink, and L. C. Coates. "AB0778 ASSOCIATION BETWEEN PATIENT-REPORTED OUTCOMES AND DISEASE ACTIVITY IN BIMEKIZUMAB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1687.1–1687. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4204.
Full textWahyuni, Anna Tri, Masfuri Masfuri, and Liya Arista. "FAKTOR-FAKTOR YANG MEMPENGARUHI MORTALITAS PADA PASIEN DENGAN FRAKTUR COSTA: Literature Review." Jurnal Keperawatan Widya Gantari Indonesia 6, no. 2 (July 20, 2022): 157. http://dx.doi.org/10.52020/jkwgi.v6i2.4151.
Full textMI KANG, YU, GIORGIO E. M. MELLONI, AVIVIT CAHN, ITAMAR RAZ, FILIPE MOURA, DEEPAK L. BHATT, SILVIO E. INZUCCHI, et al. "1896-LB: Clinical Features and C-Peptide Levels Associated with Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Dapagliflozin vs. Placebo—Insights from DECLARE-TIMI 58." Diabetes 73, Supplement_1 (June 14, 2024). http://dx.doi.org/10.2337/db24-1896-lb.
Full textMI KANG, YU, GIORGIO E. M. MELLONI, AVIVIT CAHN, ITAMAR RAZ, FILIPE MOURA, DEEPAK L. BHATT, SILVIO E. INZUCCHI, et al. "1895-LB: Fasting C-Peptide and Type 1 Diabetes Polygenic Score Predict Diabetic Ketoacidosis in People with Type 2 Diabetes in DECLARE-TIMI 58." Diabetes 73, Supplement_1 (June 14, 2024). http://dx.doi.org/10.2337/db24-1895-lb.
Full textGao, Xiang. "A ‘Uniform’ for All States?" M/C Journal 26, no. 1 (March 15, 2023). http://dx.doi.org/10.5204/mcj.2962.
Full textGoggin, Gerard, and Christopher Newell. "Fame and Disability." M/C Journal 7, no. 5 (November 1, 2004). http://dx.doi.org/10.5204/mcj.2404.
Full textFelton, Emma. "Brisbane: Urban Construction, Suburban Dreaming." M/C Journal 14, no. 4 (August 22, 2011). http://dx.doi.org/10.5204/mcj.376.
Full textHarrison, Karey. "Building Resilient Communities." M/C Journal 16, no. 5 (August 24, 2013). http://dx.doi.org/10.5204/mcj.716.
Full textLyons, Craig, Alexandra Crosby, and H. Morgan-Harris. "Going on a Field Trip: Critical Geographical Walking Tours and Tactical Media as Urban Praxis in Sydney, Australia." M/C Journal 21, no. 4 (October 15, 2018). http://dx.doi.org/10.5204/mcj.1446.
Full textRaffa, Taylor, Parker Chang, Babak Sarani, and Susan Kartiko. "Surgical Stabilization of Rib Fractures: A Review of the Indications, Technique, and Outcomes." Medical Research Archives 11, no. 11 (2023). http://dx.doi.org/10.18103/mra.v11i11.4694.
Full textBrien, Donna Lee. "From Waste to Superbrand: The Uneasy Relationship between Vegemite and Its Origins." M/C Journal 13, no. 4 (August 18, 2010). http://dx.doi.org/10.5204/mcj.245.
Full text